Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CADOCHINE-TRIAL
ChiCTR2000028986Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis comparing Calcium dobesilate with Placebo (2 arms). Primary endpoint: Albumin-to-creatinine ratio (ACR). Started Sep 2017; status: recruiting.
02
Drugs
calcium dobesilate
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2000028986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028986.